Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 05 - 31 tags : Application save search
FSD PHARMA FILES INVESTIGATIONAL NEW DRUG APPLICATION (“IND”) WITH FDA AND HEALTH CANADA FOR PHASE-2 TRIAL OF FSD-201 FOR AN INFLAMMATORY DISORDER
Published: 2022-05-31 (Crawled : 07:00) - fsdpharma.com
HUGE | $0.6167 1.22% 29K
|
Process Industries
|
| O: -1.09%
H: 1.1%
C: -1.92%
fsd-201 fda pharma drug canada health application trial phase 2
Lexicon Resubmits New Drug Application for Sotagliflozin for the Treatment of Heart Failure
Published: 2022-05-31 (Crawled : 21:00) - biospace.com/
LXRX | News | $1.655 1.53% 470K
|
Health Technology
|
| O: 1.72%
H: 5.65%
C: 0.0%
treatment drug heart application
Y-mAbs Announces FDA Acceptance of Biologics License Application for OMBLASTYS® (omburtamab) for the Treatment of Neuroblastoma for Priority Review
Published: 2022-05-31 (Crawled : 18:00) - biospace.com/
YMAB | $15.14 0.93% 70K
|
Health Technology
|
| O: -0.51%
H: 11.03%
C: 7.24%
omblastys treatment fda application license review
Janux Therapeutics Announces FDA Clearance of Investigational New Drug Application for JANX007, a PSMA-TRACTr for Metastatic Castration-Resistant Prostate Cancer
Published: 2022-05-31 (Crawled : 18:00) - biospace.com/
JANX | $47.84 -2.07% 76K
|
Professional, Scientific, and T...
|
| O: 0.6%
H: 0.25%
C: -5.6%
janx007 fda clearance drug application therapeutics cancer prostate cancer
Koil Energy Solutions to Provide Cable Management Services for Military Application
Published: 2022-05-31 (Crawled : 13:20) - globenewswire.com
DPDW | $0.58
|
Manufacturing
|
| O: 1.45%
H: 0.0%
C: 0.0%
management solutions energy services application military
Cybin Submits IND Application to FDA for its Phase 1/2a First-in-Human Trial of CYB003 for the Treatment of Major Depressive Disorder
Published: 2022-05-31 (Crawled : 13:00) - biospace.com/
CYBN | News | $0.3651 -1.3% 420K
|
n/a
|
| O: 6.13%
H: 3.93%
C: 0.0%
cyb003 treatment fda application trial phase 1 major depressive disorder
FSD Pharma Files Investigational New Drug Application (“IND”) with FDA and Health Canada for Phase-2 Trial of FSD-201 for an Inflammatory disorder and Provides Corporate Updates
Published: 2022-05-31 (Crawled : 13:00) - biospace.com/
HUGE | $0.6167 1.22% 29K
|
Process Industries
|
| O: -1.09%
H: 1.1%
C: -1.92%
fsd-201 fda pharma drug canada health application trial phase 2
Outlook Therapeutics Provides Update on Biologics License Application (BLA) Submission for ONS-5010 as a Treatment for Wet AMD
Published: 2022-05-31 (Crawled : 12:20) - globenewswire.com
OTLK P | $8.375 1.03% 63K
|
Health Technology
|
| O: -48.46%
H: 60.24%
C: 43.97%
ons-5010 treatment application license therapeutics submission
TScan Therapeutics Announces FDA Clearance of Investigational New Drug Application for TSC-101 for the Treatment of Hematologic Malignancies
Published: 2022-05-31 (Crawled : 12:00) - biospace.com/
TCRX 1 d | $6.98 0.87% 39K
|
Professional, Scientific, and T...
|
| O: -1.23%
H: 4.05%
C: -0.31%
tsc-101 treatment fda clearance drug application therapeutics
Gainers vs Losers
| 82% | 18% |
Top 10 Gainers
AGBA | News | $1.37 242.5% 76M
|
Finance
EGOX | $0.0606 68.33% 250M
|
CHRO | $1.73 41.22% 46K
|
n/a
ZCMD | $1.98 36.55% 27M
|
Commercial Services
RWOD | $10.61 32.68% 5.1M
|
n/a
NVFY | $2.77 31.28% 2.2M
|
Consumer Durables
AULT | $0.304 25.57% 47M
|
Manufacturing
WISA 4 | $7.19 22.07% 18M
|
Electronic Technology
MCB 4 | $39.53 19.43% 88K
|
Finance
PRTG | $0.285 18.75% 170K
|
Mining, Quarrying, and Oil and ...
Your saved searches
Save your searches and get alerts when important news are released.